BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8780043)

  • 1. 2-Deoxy-2-fluoro-D-glucose as a functional probe for NMR: the unique metabolism beyond its 6-phosphate.
    Kanazawa Y; Yamane H; Shinohara S; Kuribayashi S; Momozono Y; Yamato Y; Kojima M; Masuda K
    J Neurochem; 1996 May; 66(5):2113-20. PubMed ID: 8780043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of energy metabolism in brain using epimerization of 2-deoxy-2-fluoro-D-glucose by 19F NMR: the effect of anesthesia.
    Shinohara S; Kanazawa Y; Kojima M
    Magn Reson Med; 1991 Oct; 21(2):191-6. PubMed ID: 1745118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 19F NMR of 2-deoxy-2-fluoro-D-glucose for tumor diagnosis in mice. An NDP-bound hexose analog as a new NMR target for imaging.
    Kanazawa Y; Umayahara K; Shimmura T; Yamashita T
    NMR Biomed; 1997 Jan; 10(1):35-41. PubMed ID: 9251114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic pathway of 2-deoxy-2-fluoro-D-glucose studied by F-19 NMR.
    Kanazawa Y; Momozono Y; Ishikawa M; Yamada T; Yamane H; Haradahira T; Maeda M; Kojima M
    Life Sci; 1986 Aug; 39(8):737-42. PubMed ID: 3736344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral metabolism of fluorodeoxyglucose measured with 19F NMR spectroscopy.
    Pouremad R; Wyrwicz AM
    NMR Biomed; 1991 Aug; 4(4):161-6. PubMed ID: 1931555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of stereoisomers involved products of synthesized 18F-2-deoxy-2-fluoro-D-glucose by 1H-NMR spectroscopy].
    Imazeki K; Erata T; Okada J; Yoshikawa K; Uno K; Arimizu N; Yoshizawa T; Nose T
    Kaku Igaku; 1992 May; 29(5):639-42. PubMed ID: 1434079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive in vivo demonstration of 2-fluoro-2-deoxy-D-glucose metabolism beyond the hexokinase reaction in rat brain by 19F nuclear magnetic resonance spectroscopy.
    Nakada T; Kwee IL; Conboy CB
    J Neurochem; 1986 Jan; 46(1):198-201. PubMed ID: 3940280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal effects of 2-fluoro-2-deoxy-D-glucose and glucose on their metabolism in Saccharomyces cerevisiae studied by multi-nuclear NMR spectroscopy.
    Tran-Dinh S; Courtois A; Wietzerbin J; Bouet F; Herve M
    Biochimie; 1995; 77(4):233-9. PubMed ID: 8589050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
    Wienhard K; Pawlik G; Nebeling B; Rudolf J; Fink G; Hamacher K; Stöcklin G; Heiss WD
    J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive demonstration of in vivo 3-fluoro-3-deoxy-D-glucose metabolism in rat brain by 19F nuclear magnetic resonance spectroscopy: suitable probe for monitoring cerebral aldose reductase activities.
    Kwee IL; Nakada T; Card PJ
    J Neurochem; 1987 Aug; 49(2):428-33. PubMed ID: 3110372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 2-fluoro-2-deoxy-D-glucose metabolites by 19F(1H) hetero-RELAY.
    O'Connell TM; London RE
    J Magn Reson B; 1995 Dec; 109(3):264-9. PubMed ID: 8542195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: a new tracer for cancer detection.
    Fukuda H; Matsuzawa T; Abe Y; Endo S; Yamada K; Kubota K; Hatazawa J; Sato T; Ito M; Takahashi T; Iwata R; Ido T
    Eur J Nucl Med; 1982; 7(7):294-7. PubMed ID: 6981508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synthesis of 2-[F-18]fluoro-2-deoxy-D-glucose using glycals: a reexamination.
    Bida GT; Satyamurthy N; Barrio JR
    J Nucl Med; 1984 Dec; 25(12):1327-34. PubMed ID: 6502255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorine-19 NMR imaging of glucose metabolism.
    Nakada T; Kwee IL; Card PJ; Matwiyoff NA; Griffey BV; Griffey RH
    Magn Reson Med; 1988 Mar; 6(3):307-13. PubMed ID: 3362066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolism of 18F-FDG (2-fluoro-2-deoxy-D-glucose) in tumor cells].
    Shimmura T; Nemoto M; Ino S; Kurami M
    Kaku Igaku; 2003 Feb; 40(1):31-8. PubMed ID: 12701205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and purification of 2-deoxy-2-[18F]fluoro-D-glucose and 2-deoxy-2-[18F]fluoro-D-mannose: characterization of products by 1H- and 19F-NMR spectroscopy.
    Oberdorfer F; Hull WE; Traving BC; Maier-Borst W
    Int J Rad Appl Instrum A; 1986; 37(8):695-701. PubMed ID: 3021670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific differences in 2-fluoro-2-deoxyglucose metabolism beyond FDG-6-P: a 19F NMR spectroscopy study in the rat.
    Southworth R; Parry CR; Parkes HG; Medina RA; Garlick PB
    NMR Biomed; 2003 Dec; 16(8):494-502. PubMed ID: 14696007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography.
    Osman S; Danpure HJ
    Int J Rad Appl Instrum B; 1992 Feb; 19(2):183-90. PubMed ID: 1601671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A kinetic comparison of [18F]2-fluoro-2-deoxyglucose and [18F]2-fluoro-2-deoxymannose using positron emission tomography.
    Braun AR; Carson RE; Adams HR; Finn RD; Francis BE; Herscovitch P
    Nucl Med Biol; 1994 Aug; 21(6):857-63. PubMed ID: 9234335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characterization of 2-deoxy-2-18F-fluoro-D-mannose as a tumor-imaging agent for PET.
    Furumoto S; Shinbo R; Iwata R; Ishikawa Y; Yanai K; Yoshioka T; Fukuda H
    J Nucl Med; 2013 Aug; 54(8):1354-61. PubMed ID: 23843565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.